Company intelligence / Profile preview

Envomed

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Envomed has developed an on-site medical waste treatment device that shreds and sterilizes hazardous/infectious medical waste using chemical sterilization. The system meets STAATT level IV sterilization standards and reduces volume by up to 90%. It enables hospitals and labs to treat their own waste safely, cost-effectively, and sustainably onsite. The company has won innovation awards including the Climate Solutions Prize Startup Track Winner in May 2024.

Modalities: Device (medical waste sterilization and shredding system)
Industry: Therapeutic Medical Devices

Partnerships

Takeda (joint development of a dedicated system for laboratory plastic/plasma industry challenge; implementation planned for Takeda labs in the US)

Beyond the preview

Go deeper on Envomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envomed.

Explore the full profile